ELAB PMGC Holdings Inc.

$4.52▼ -1.74% Healthcare Other
After hours $4.49▼ -0.66% Sep 11, 7:54 PM ET
Volume 11.2K Avg Volume (10D) 35.4K
Key Metrics & Fundamentals
Market Cap
$3.66M
P/E Ratio
–
Div Yield
–%
52W Range
4.40 - 2671.20
% vs 50 MA
-46.44%
% vs 200 MA
-97.18%
RSI-14
25.1
MACD Histogram
+0.0400
Beta (1Y vs SPY)
3.78
Free Cash Flow
-$1.96M
Gross Rev
$1.31M
Gross Profit
$385,691
EBITDA
-$3.48M
COGS
$920,919
Operating Exp
$4.20M
Operating Income
-$3.82M
EBIT
-$3.82M
Pretax Income
-$2.96M
Net Income
-$2.94M
EPS (Diluted)
-0.60
Price & Volume History
Loading chart…
Recent News
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
GlobeNewswire · Sep 1, 2026 11:45 AM
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
GlobeNewswire · Aug 26, 2026 12:17 PM
PMGC Holdings Signs Orbit2Orbit Term Sheet for Microgravity Muscle Research
InvestorsHub · Aug 25, 2026 1:46 PM
PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss
GlobeNewswire · Aug 25, 2026 11:30 AM
NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
GlobeNewswire · Aug 21, 2026 1:30 PM
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
GlobeNewswire · Aug 19, 2026 3:45 PM
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially
GlobeNewswire · Aug 14, 2026 1:31 PM
PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities Requirement
GlobeNewswire · Jul 29, 2026 7:54 PM
PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.
GlobeNewswire · Jul 28, 2026 11:30 AM
NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License
GlobeNewswire · Jul 27, 2026 11:30 AM
Financial Overview - Income Statement Quarterly

See ELAB's money flow as a full page

Social Sentiment
Avg +0.72 · 6 posts
NewsDiscussionTradeELAB Short Interest
r/wallstreetbets · Feb 10, 2026
The user expresses cautious optimism about a potential 'squeeze' and a recent position taken, indicating a positive sentiment.
positive +0.60
DDNewsPriceTargetDiscussionELAB
r/wallstreetbets · Jul 2, 2025
The post expresses a bullish outlook, citing factors like low float, M&A activity, and potential catalysts.
positive +0.80
DDTradeDiscussion$elab/pmgc an hidden gem for 2025. Going long and holding strong.
r/wallstreetbets · Jan 17, 2025
The author expresses a bullish outlook and highlights positive aspects like low debt and cash reserves.
positive +0.80
DDDiscussion$ELAB still moving under the radar.
r/wallstreetbets · Dec 17, 2024
The author expresses strong belief in the company's undervaluation and future potential.
positive +0.80
DDTradeDiscussionIs $ELAB the last one?
r/wallstreetbets · Dec 3, 2024
The author expresses optimism about ELAB's potential and describes it as 'undervalued and oversold', seeking a 'swing run'.
positive +0.60
Page 1 of 2 (6 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙